top of page

CLINICAL CASE

Left Common Carotid Artery Pseudoaneurysm After Unwitnessed Lithium Button Battery Ingestion in a Toddler: Successful Endovascular Hemostasis Following Life-Threatening Bleeding

Gia Bibilashvili1, Erekle Ekvtimishvili2, Zurab Goginashvili3,  Shota Ingorokva4,ID, Luka Lekashvili4, Vasil Javakhidze4,
Neli Iakobidze
2, Nino Giorgadze5,  Nino Petriashvili1, Ketevan Barabadze6, Vakhtang Katsarava7,

Gvantsa Khachiashvili9,ID, Levan Chelidze8,ID, Natia Epremidze9,ID, Kakhaber Chelidze9,ID

Received: 20 Feb 2026; Accepted: 9 Mar 2026; Available online: 10 Mar 2026
ABSTRACT
The landscape of pediatric injury has shifted dramatically alongside the strategic evolution of household electronics. As consumer technology pursues extreme miniaturization, manufacturers have increasingly transitioned to high-energy-density lithium-ion chemistries. The strategic challenge for the clinician is that a battery small enough to be swallowed by infants and toddlers is often large enough to bridge the esophageal lumen, initiating catastrophic tissue destruction within minutes. Commonly, mucosal injury begins within 15 minutes, and full-thickness burns can occur within 2-4 hours, with severe complications, such as vocal cord paralysis, spondylodiscitis, aorto-esophageal stricture/stenosis, tracheoesophageal fistula (TEF), or aorto-esophageal fistula (AEF). In the article, we present a successful multidisciplinary management of an extremely rare clinical case: a 2-year-old female patient with trisomy 21 who experienced severe bleeding from a left carotid pseudoaneurysm following ingestion of a CR2032 3V Lithium button battery, treated with endovascular repair. This case highlights that (i) severe injury may evolve despite early removal, (ii) bleeding after button battery ingestion warrants urgent vascular evaluation, and (iii) carotid-esophageal fistula, though rare, should be considered in recurrent bright-red hematemesis following esophageal button battery injury
Keywords: Button battery ingestion; esophageal injury; carotid-esophageal fistula; pseudoaneurysm; mediastinitis; endovascular therapy; pediatric hemorrhage.

DOI: 10.52340/GBMN.2026.01.01.161
INTRODUCTION

Battery ingestion is a time-critical pediatric emergency, particularly when a button battery becomes lodged in the esophagus. Although many ingested batteries pass uneventfully through the gastrointestinal tract, esophageal impaction can cause severe caustic injury within hours and may lead to perforation, fistulization, hemorrhage, and death. A practical clinical framework should therefore distinguish between button batteries (coin/disk cells) and cylindrical batteries (e.g., AA/AAA types), because their injury profiles and management pathways differ.1-3

​

As defined by current clinical surveillance, button batteries (also known as coin or disk batteries) are characterized by:4

  • Dimensions: Typically, 5-25 mm in diameter and 1-6 mm in height. The 20 mm diameter lithium cell is the most significant driver of severe morbidity due to its propensity for esophageal impaction.

  • Chemistry: Formulations include lithium, silver, zinc, and heavy metals such as nickel, cadmium, and mercury.

  • Caustic Electrolytes: High concentrations of potassium hydroxide or sodium hydroxide.

 

Epidemiology and demographics

Across contemporary datasets, young children—especially those under 6 years of age—are the highest-risk group. In the Canadian poison-center analysis, 62% of Canadian Surveillance System for Poison Information (CSSPI) system cases and 69% of British Columbia Drug and Poison Information Centre (DPIC) cases occurred in children under 6 years; in the Dutch national pediatric surveillance study, the median age was 2.8 years, and the population-related incidence was 1.18 per 100,000 children per year. In the Lisbon tertiary-center pediatric series, the median age was 26 months, reinforcing the observation that the most serious cases cluster in toddlers.2,3,5

​

Male predominance is slight and inconsistent across datasets, so it is more accurate to state that the sex distribution is roughly balanced, with a small male excess in some cohorts, rather than overinterpreting it. In addition, the Canadian surveillance paper identified a meaningful secondary risk group among adults older than 59 years, often involving hearing-aid batteries mistaken for pills. The same paper also showed that poison-center data are useful for surveillance but likely underestimate true clinical burden and long-term complications, so those rates should not be presented as definitive population incidence without qualification.3

​

A cautious summary of exposure source is that most pediatric ingestions occur in household settings, commonly involving batteries from consumer products such as hearing aids, toys, watches, flashlights, and other small electronic devices.3,6

​

Pathophysiology and mechanisms of Injury

The dominant mechanism of severe esophageal injury is electrolyte-mediated tissue injury, not simple leakage alone. When a button battery contacts esophageal mucosa, the tissue completes an electrical circuit, generating hydroxide ions at the negative pole and rapidly creating a highly alkaline environment that causes liquefactive necrosis. Pressure necrosis and leakage of alkaline contents may contribute, but electrolysis is considered the principal driver of injury. It is a dangerous misconception that "spent" or "dead" batteries are safe. Even batteries that no longer power a device retain sufficient residual voltage to drive the 2nd-order hydrolysis reactions required for full-thickness burns.1,7

​

Mucosal injury may begin within 15 minutes, and severe injury can develop within 2 hours; therefore, esophageal impaction is treated as an emergency. The most severe injuries are associated with larger (especially ≥20 mm) 3-V lithium button batteries, particularly in small children, because these cells are both more likely to lodge and to generate rapid alkaline injury. Crucially, while destruction is rapid, the clinical diagnosis of perforation is often delayed; evidence suggests perforation is rarely diagnosed within the first 12 hours, creating a period of deceptive clinical stability that must not lead to complacency.1,2,6

​

By contrast, ingestion of cylindrical batteries is usually low risk and often amenable to conservative management, but it is not benign in all cases. In the 2025 pediatric cylindrical battery series, conservative management was appropriate for most children. However, the authors specifically advised timely removal when the battery is A23 or A27 type, damaged, retained, or associated with symptoms, multiple ingestion, or prior abdominal surgery.8

​

Clinical presentation: witnessed vs unwitnessed ingestion

Clinical presentation is often nonspecific, and unwitnessed ingestion is especially dangerous because diagnosis is delayed until complications develop. Acute presentations of witnessed ingestion are more likely to include vomiting, drooling, dysphagia, irritability, coughing, stridor, and respiratory distress. In contrast, delayed presentations may include fever, refusal to feed, hematemesis, melena, neck pain/stiffness, cough, hoarseness, or sudden hemorrhage.1,2

​

One useful data point from the Lisbon tertiary-center series is that symptoms were present in 100% of esophageal battery cases but only 24% of gastric battery cases. This is a good teaching point, but it should be identified as a single-center observational finding rather than a universal rule.2

​

A key red flag is mid-esophageal impaction, which carries the greatest concern for aortoesophageal fistula (AEF) because of proximity to the aorta. Hematemesis or melena in this setting should be treated as a warning sign of advanced injury and possible vascular involvement.1

​

Diagnostic imaging

Any suspected battery ingestion requires urgent radiographic evaluation, ideally with two views (Ateroposterior and lateral), including the entire neck, chest, and abdomen. On AP view, clinicians should look for the double-ring / halo sign, representing the battery’s two-layer construction; on lateral view, they should assess for the step-off sign, which helps distinguish a button battery from a coin and identifies the negative pole orientation.1,9

​

Advanced imaging is indicated when there is concern for complications. Computed Tomography (CT) or Magnetic-Resonance Imaging (MRI) after battery removal is recommended when there are severe symptoms, evidence of mucosal injury, suspected perforation/fistulization, or delayed diagnosis (e.g., first confirmation or removal more than 12 hours after ingestion), because cross-sectional imaging helps assess mediastinal injury and proximity to major vessels.1

​

Emergency intervention and management timeframes

Management is highly time-sensitive. If ingestion is suspected, immediate two-view X-rays should be obtained. If the child is 12 months or older, the ingestion was likely within 12 hours, the child is stable and able to swallow, and perforation is not suspected, it is reasonable to administer 10 mL (2 teaspoons) of honey every 10 minutes for up to 6 doses en route to endoscopy. In a clinical setting, sucralfate suspension 1 g/10 mL may also be given as 10 mL every 10 minutes for up to 3 doses. These measures may reduce injury severity, but must never delay endoscopic removal.1,9,10

​

If a button battery is in the esophagus, immediate endoscopic removal is mandatory, ideally within 2 hours. The intervention should not be delayed for fasting status. Endoscopic inspection should document injury depth, location, and battery orientation, because these features guide risk stratification for airway and vascular complications.1,2,9

​

For batteries beyond the esophagus, management is more selective. In asymptomatic children, observation is often appropriate. However, retrieval should be considered if symptoms develop, if a magnet was co-ingested, or if a large battery persists in the stomach, especially in younger children. The National Capital Poison Center uses age- and size-based thresholds (for example, persistent ≥15 mm gastric batteries in children <6 years), whereas ESPGHAN allows observation in many asymptomatic cases with follow-up imaging; this should be presented as a guideline-dependent decision, not a single universal rule.1,9

​

After removal, if there is no perforation, the injured area may be irrigated endoscopically with 50–150 mL of 0.25% sterile acetic acid. This is a reasonable mitigation strategy, but the evidence base is limited and largely derived from animal/preclinical work and a very small pediatric series, so it should be described as an adjunct rather than a fully established standard.1,9,11

​

Clinical outcomes and complications

The most serious injuries are associated with esophageal impaction. In the Lisbon series, all patients with esophageal batteries had severe mucosal injury, acute complications occurred in more than half, and later stenosis was common. Severe tissue injury can occur within hours, but frank perforation is usually identified within 2 days, not necessarily within the first 2 hours.1,2

​

Important complications include esophageal perforation, mediastinitis, tracheoesophageal fistula, recurrent laryngeal nerve injury/vocal cord paralysis, esophageal stricture, and aortoesophageal fistula. Delayed catastrophic bleeding remains a central concern: ESPGHAN notes that fistulas can present up to 4 weeks after removal, and the poison-center guideline reports that esophageal-vascular fistulas may present up to 27 days after removal. This justifies prolonged clinical vigilance, especially after mid-esophageal injury or any sentinel bleeding.1,5,9,12

CASE

A 2-year-old girl with trisomy 21 (Down syndrome) and a history of neonatal surgery for intestinal obstruction (restoration of bowel patency) was admitted in February 2026 to the Emergency Department of TSMU and Ingorokva High Medical Technology University Clinic due to unexplained oral bleeding and hemorrhagic shock.

​

Symptoms started 11 days before admission in the evening with the onset of crying and hypersalivation. The following morning, the patient was consulted by a primary care physician, who diagnosed a viral infection and discharged the patient home with appropriate recommendations (Day 0). However, the child subsequently refused food and fluids, continued to cry, and developed marked sialorrhea, followed by fever, prompting an ambulance call (112). The patient was hospitalized at the Pediatric Clinic on the second day of symptom initiation. The AP radiograph revealed a round, radiopaque, metallic-density shadow at the level of the neck. The patient was placed on mechanical ventilation, and direct laryngoscopy identified a coin-shaped (“button-like”) foreign body at the upper esophageal constriction. The adjacent mucosa was covered with black, necrotic-appearing deposits and easily bled upon mechanical contact. The foreign body was removed using extraction forceps, with technical difficulty (Fig.1). Given the increased risk of esophageal perforation, advancing a flexible endoscope distal to the burn was deemed inappropriate. Following the procedure, the patient was transferred to the Pediatric Intensive Care Unit and, two days later, to the thoracic surgery department.


FIGURE 1. Extracted Lithium button battery

Extracted Lithium button battery

Patient was discharged due to clinical improvement (she tolerated small amounts of water and food) and was scheduled for follow-up esophagogoscopy in 3 weeks.

​

Two days after discharge, the patient developed vomiting with large volumes of blood and was admitted to the ICU of our clinic with signs of hemorrhagic shock, respiratory distress, stridor, and somnolence. After starting mechanical ventilation, hemostatic therapy, and infusion-transfusion resuscitation, hemodynamic stabilization was achieved, and active bleeding was no longer visualized.

​

The urgent CTA scan revealed radiologic signs of esophageal perforation, mediastinitis, and a pseudoaneurysm of the left common carotid artery at approximately the C5-C6 vertebral level (Fig.2).


FIGURE 2. 3D CT angiography reconstruction of the left common carotid artery (red arrow) pseudoaneurysm (black arrow)

3D CT angiography reconstruction of the left common carotid artery (red arrow) pseudoaneurysm (black arrow)

Considering safety and a minimally invasive approach, especially after a massive bleeding episode, endovascular embolization of the aneurysm was selected as the preferred method of therapy.

​

Access was obtained via open surgery puncture of the right femoral artery using a 5F introducer. A guiding catheter, specifically a Cordis Envoy 5F, was positioned in the left common carotid artery. Digital subtraction angiography (DSA) confirmed a pseudoaneurysm of the left common carotid artery (LCCA), measuring approximately 7 mm in diameter, with a regular shape and a diverticulum at its apex (Fig.3A).

​

Using a microcatheter (Headway 17) and a microguidewire (Traxcess 14), the pseudoaneurysm was catheterized. Detachable coils were deployed inside the aneurysm sac (Fig.3B), including Microplex coils (Terumo) of sizes 7 mm/31 cm, 6 mm/20 cm, 5 mm/20 cm, 5 mm/15 cm, and 4 mm/12 cm. Final DSA demonstrated complete occlusion of the pseudoaneurysm from the circulation, with no complications (Fig.3C and Fig.3D).


FIGURE 3.The left carotid artery pseudoaneurysm occlusion
image.png
image.png
Explanations: A. The left common carotid artery (LCCA) before intervention (CT angiography image); B. Detachable coils deployed inside the aneurysm sac; C and D. demonstrated complete occlusion of the pseudoaneurysm from the circulation without complications.   
​
After endovascular closure, no further episodes of active hemorrhage were observed, and the patient’s condition stabilized. Follow-up on esophageal healing, swallowing function, neurologic status, and surveillance imaging was planned.
DISCUSSION

There is no reliable published population incidence for carotid-esophageal fistula after button battery ingestion. The current literature does not provide a denominator-based rate for this specific lesion; instead, it is reported as an exceptionally rare vascular complication within case reports and small series.13,14

​

The best systematic review available found that, among 361 children with severe complications or death after button battery ingestion, 51% had vascular injuries. About 75% of those vascular injuries were aorto-esophageal fistulas, and the remaining minority were pooled as other non-aortic vascular lesions. That means the incidence of carotid-esophageal fistula was not separately quantified.13,14

​

Formation of the carotid pseudoaneurysm following button battery ingestion is extraordinarily rare, with the literature still at the level of isolated case reports:

  • a pediatric case of left common carotid-esophageal fistula after button battery ingestion that later progressed to a pseudoaneurysm, treated with a flow-diversion stent,14 and

  • a separate 2025 pediatric case of catastrophic upper GI bleeding from a left common carotid pseudoaneurysm after button battery ingestion.15

 

The management of the pseudoaneurysm and associated fistula is usually multidisciplinary and staged: (i) bleeding control, (ii) vascular anatomy visualization, (iii) bridge technique if necessary, and (iv) vascular and esophageal damage repair.16

​

The repair of the vascular lesion depends on anatomy, contamination, and hemodynamic stability. Reported options include:

  • Primary repair/oversewing of the arterial defect.14

  • Patch repair (patch angioplasty), including bovine pericardial patch repair.14

  • Segmental resection with reconstruction/anastomosis of the injured vessel.14

  • Interposition graft replacement: (i) Polytetrafluoroethylene (PTFE)/Gore-Tex graft for carotid reconstruction, and (ii) Dacron / Gelweave graft for aortic repairs.14

  • Covered endovascular stent-graft as emergency closure of the fistula or pseudoaneurysm, especially in unstable patients.14,17

  • Flow-diversion stent for delayed carotid pseudoaneurysm after fistula repair.14

 

For carotid lesions, the key extra issue is cerebral perfusion:14,17

  • Neuroangiographic assessment of collateral flow / Circle of Willis is important before accepting carotid sacrifice.

  • If collateral flow is inadequate, carotid reconstruction/preservation is favored over simple sacrifice.

 

According to the systematic review, the most common site of button battery ingestion was the upper esophagus in 47% of total cases, which was also associated with the highest percentage of non-fatal outcomes, with 86.9% survival rate.13 The same location was identified in our patient.

​

As it was mentioned, cerebrovascular events may be one of the serious complications of bleeding itself and intraoperative cerebral hypoperfusion as well.15 Despite the severity of bleeding, rare localization of the pseudoaneurysm/fistula, and intervention carried out under extreme conditions, there were no cerebrovascular complications in our case.

CONCLUSIONS

In toddlers, unwitnessed button battery ingestion can culminate in delayed, life-threatening vascular injury even after apparent recovery. Recurrent or massive bright-red hematemesis after esophageal button battery injury should be treated as a sentinel sign warranting urgent vascular imaging (CTA/angiography) and multidisciplinary management planning. Endovascular closure of a carotid-esophageal fistula can be lifesaving in selected patients.

AUTHOR AFFILIATION

1Pediatric Intensive Care Unit, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia;

2Endovascular Neurosurgery Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia;

3Plastic, Reconstructive and Vascular Surgery Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia;

4Plastic, Reconstructive and Vascular Surgery Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia;

5Anesthesiology Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia.

6Pediatric Department, Tbilisi State Medical University and Ingorokva High Medical TechnologyUniversity Clinic, Tbilisi, Georgia.

7Thoracic Surgery Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia;

8Vascular and Cardiac Surgery Department, Tbilisi Heart Center, Tbilisi, Georgia;

9Internal Medicine Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia.

INFORMED CONSENT

Written informed consent for publication was obtained from the patient’s legal guardian, and all identifying details were removed/modified to protect privacy.

ACKNOWLEDGEMENTS

Portions of the manuscript were edited for clarity and grammar using an artificial intelligence-based language model (ChatGPT, OpenAI; model: GPT-5.2 Thinking. San Francisco, CA, USA). The authors reviewed and verified all content and take full responsibility for the manuscript.

REFERENCES
  1. Solano-López J, Zamorano JL, Sanz AP, Amat-Santos I, Sarnago F, Ibañes EG, et al. Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak. Revista Española de Cardiología. 2020;73(12):985 − 93.

  2. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA cardiology. 2020;5(7):831 − 40.

  3. Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, et al. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation. 2020;141(25):2113-6.

  4. Ozbeyaz NB, Gokalp G, Algul E, Sahan HF, Aydinyilmaz F, Guliyev I, Kalkan K. H2FPEF Score and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Angiology. 2023;74(2):181–188.

  5. Song Y, Gao P, Ran T, Qian H, Guo F, Chang L, et al. High inflammatory burden: a potential cause of myocardial injury in critically ill patients with COVID-19. Frontiers in cardiovascular medicine. 2020;7:128.

  6. Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clinical immunology. 2020;214:108393.

  7. Ulhaq ZS, Soraya GV. Interleukin-6 as a potential biomarker of COVID-19 progression. Medecine et maladies infectieuses. 2020;50(4):382. \

  8. Nguyen N, Nguyen H, Ukoha C, Hoang L, Patel C, Ikram FG, et al., editors. Relation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events. Baylor University Medical Center Proceedings; 2022: Taylor & Francis.

  9. Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron L, Pagliaro P, et al. (2020) COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Geroscience.;42(4):1021-49.

  10. Schuett H, Oestreich R, Waetzig GH, et al. "Interleukin-6 signaling in the pathogenesis of atherosclerosis." Atherosclerosis. 2009;202(1):17-25.

  11. Zhang C, Wu Z, Li JW, et al. "Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality." Int J Antimicrob Agents. 2020;55(5):105954.

  12. Kanda T, Takahashi T. "Interleukin-6 and cardiovascular diseases." Jpn Heart J. 2004;45(2):183-193.

  13. Connolly SJ, Pogue J, Eikelboom J, et al. "Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range." Circulation. 2008;118(20):2029-2037.

  14. Tang N, Li D, Wang X, Sun Z. "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia." J Thromb Haemost. 2020;18(4):844-847.  Gabay C. "Interleukin-6 and chronic inflammation." Arthritis Res Ther. 2006;8 Suppl 2(Suppl 2):S3.

  15. Libby P, Ridker PM, Maseri A. "Inflammation and atherosclerosis." Circulation. 2002;105(9):1135-1143.

  16. Levi M, van der Poll T. "Inflammation and coagulation." Crit Care Med. 2010;38(2 Suppl):S26-S34.

  17. Huang C, Wang Y, Li X, et al. "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China." Lancet. 2020;395(10223):497-506.

  18. Zhou F, Yu T, Du R, et al. "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study." Lancet. 2020;395(10229):1054-1062.

  19. Ruan Q, Yang K, Wang W, Jiang L, Song J. "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China." Intensive Care Med. 2020;46(5):846-848.

  20. Guo T, Fan Y, Chen M, et al. "Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)." JAMA Cardiol. 2020;5(7):811-818.

  21. Klok FA, Kruip MJHA, van der Meer NJM, et al. "Incidence of thrombotic complications in critically ill ICU patients with COVID-19." Thromb Res. 2020;191:145-147.

  22. Guan WJ, Ni ZY, Hu Y, et al. "Clinical characteristics of coronavirus disease 2019 in China." N Engl J Med. 2020;382(18):1708-1720.

  23. Wu C, Chen X, Cai Y, et al. "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China." JAMA Intern Med. 2020;180(7):934-943.

  24. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. "Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men." Circulation. 2000;101(15):1767-1772.

  25. Ridker PM, Everett BM, Thuren T, et al. "Antiinflammatory therapy with canakinumab for atherosclerotic disease." N Engl J Med. 2017;377(12):1119-1131.

  26. Zhou Y, Han W, Gong D, Man C, Fan Y. "Heterogeneity of the effect of interleukin-6 receptor inhibitors on cardiovascular events: a systematic review and meta-analysis." Sci Rep. 2020;10(1):1-9.

  27. Kushner I, Katz S, Weinblatt ME. "The acute phase response is mediated by heterogeneous mechanisms." Ann N Y Acad Sci. 1989;557:19-30.

  28. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. "Chronic stress and age-related increases in the proinflammatory cytokine IL-6." Proc Natl Acad Sci U S A. 2003;100(15):9090-9095.

  29. Kaptoge S, Seshasai SR, Gao P, et al. "Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis." Eur Heart J. 2014;35(9):578-589.

  30. Tzoulaki I, Murray GD, Lee AJ, et al. "Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study." Eur Heart J. 2007;28(3):354-362.

  31. Danesh J, Kaptoge S, Mann AG, et al. "Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review." PLoS Med. 2008;5(4):e78.

  32. Libby P, Ridker PM, Hansson GK. "Progress and challenges in translating the biology of atherosclerosis." Nature. 2011;473(7347):317-325.

  33. Ferrucci L, Harris TB, Guralnik JM, et al. "Serum IL-6 level and the development of disability in older persons." J Am Geriatr Soc. 1999;47(6):639-646.

  34. Lippi G, Mattiuzzi C, Cervellin G. "Neutrophil-to-lymphocyte ratio in acute coronary syndrome: A meta-analysis." J Lab Precis Med. 2020;5:27.

  35. Verdoia M, Pergolini P, Nardin M, et al. "Neutrophil-to-lymphocyte ratio and the extent of coronary artery disease: Results from the large, prospective, multicentre Italian study." Atherosclerosis. 2019;285:7-12.

  36. Horne BD, Anderson JL, John JM, et al. "Which white blood cell subtypes predict increased cardiovascular risk?" J Am Coll Cardiol. 2005;45(10):1638-1643.

  37. Zouridakis EG, Garcia-Moll X, Kaski JC. "Usefulness of the neutrophil-to-lymphocyte ratio in predicting long-term cardiovascular outcome in patients with stable coronary artery disease." Am J Cardiol. 2007;100(5):799-803.

  38. Montazerhodjat V, Weinstock DM, Brigl M, et al. "Predicting cardiovascular events with systemic inflammatory markers: A novel role for machine learning." Circulation. 2021;143(9):894-907.

  39. Koenig W, Khuseyinova N, Löwel H, et al. "Plasma concentrations of C-reactive protein and interleukin-6 as predictors of future cardiovascular events in apparently healthy middle-aged men." Circulation. 2003;107(5):639-643.

bottom of page